Shuttle Pharmaceuticals Holdings, Inc.
SHPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001757499
In the last 90 days, Shuttle Pharmaceuticals Holdings, Inc. insiders filed 2 open-market purchases and 3 sales; 5 institutions reported holding it in 13F filings for Q2 2026, worth $338.2K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Shuttle Pharmaceuticals Holdings, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 8 | 5 | −3 |
| Shares | 158.9K | 104.2K | −54.7K (−34.4%) |
| Value | $107.4K | $338.2K | +$230.8K (+214.8%) |
New holders (3)
Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 78,597 | $255.0K | 0.00% |
| Citadel Advisors LLC | 24,354 | $79.2K | 0.00% |
| Barclays PLC | 750 | $2.44K | 0.00% |
Sold out (6)
Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Ikarian Capital, LLC | 68,993 | $46.8K |
| Geode Capital Management, LLC | 46,217 | $31.4K |
| Boothbay Fund Management, LLC | 20,360 | $13.8K |
| Virtu Financial LLC | 12,380 | $8.00K |
| UBS Group AG | 5,670 | $3.85K |
| Morgan Stanley | 27 | $18 |